Explore: Adriamycin
Discover books, insights, and more — all in one place.
Learn more about Adriamycin with top reads curated from trusted sources — all in one place.
AI-Generated Overview About “adriamycin”:
Books Results
Source: The Open Library
The Open Library Search Results
Search results from The Open Library
1Adriamycin review
“Adriamycin review” Metadata:
- Title: Adriamycin review
- Language: English
- Number of Pages: Median: 315
- Publisher: European Press Medikon
- Publish Date: 1975
- Publish Location: Ghent
- Dewey Decimal Classification: 616.994061
- Library of Congress Classification: RC-0271.00000000.A37 A37
“Adriamycin review” Subjects and Themes:
- Subjects: ➤ Cancer - Neoplasms - Adriamycin - Doxorubicin - Congresses - Drug therapy - Chemotherapy - Therapeutic use
Edition Identifiers:
- The Open Library ID: OL5022211M
- Library of Congress Control Number (LCCN): 76676994
Book Classifications
- Dewey Decimal (DDC): ➤ ❛616.994061❜.
- Library of Congress Classification (LCC): ➤ ❛RC-0271.00000000.A37 A37❜.
Access and General Info:
- First Year Published: 1975
- Is Full Text Available: No
- Is The Book Public: No
- Access Status: No_ebook
Online Marketplaces
Find Adriamycin review at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
2International Symposium on Adriamycin
By International Symposium on Adriamycin, Milan, 1971
“International Symposium on Adriamycin” Metadata:
- Title: ➤ International Symposium on Adriamycin
- Author: ➤ International Symposium on Adriamycin, Milan, 1971
- Language: English
- Number of Pages: Median: 251
- Publisher: Springer-Verlag
- Publish Date: 1972
- Publish Location: Berlin
- Dewey Decimal Classification:
- Library of Congress Classification: RM-0666.00000000 A28 I57 1971
“International Symposium on Adriamycin” Subjects and Themes:
- Subjects: Adriamycin
Edition Identifiers:
- The Open Library ID: OL22344224M
Book Classifications
- Library of Congress Classification (LCC): ➤ ❛RM-0666.00000000 A28 I57 1971❜.
Access and General Info:
- First Year Published: 1972
- Is Full Text Available: No
- Is The Book Public: No
- Access Status: No_ebook
Online Marketplaces
Find International Symposium on Adriamycin at online marketplaces:
- Amazon: Audiable, Kindle and printed editions.
- Ebay: New & used books.
Wiki
Source: Wikipedia
Wikipedia Results
Search Results from Wikipedia
Doxorubicin
Doxorubicin, sold under the brand name Adriamycin among others, is a chemotherapy medication used to treat cancer. This includes breast cancer, bladder
ABVD
protocol. It consists of concurrent treatment with the chemotherapy drugs: Adriamycin (also known as doxorubicin/hydroxydaunorubicin, designated as H in CHOP)
Chemotherapy regimen
leukemia ABVD doxorubicin (Adriamycin), bleomycin, vinblastine, dacarbazine Hodgkin's lymphoma AC doxorubicin (Adriamycin), cyclophosphamide breast cancer
Streptomyces peucetius
anthracycline antitumor antibiotics daunorubicin and doxorubicin (also known as adriamycin). Recent work has identified an antibacterial macrolide, peucemycin, with
CHOP (chemotherapy)
formation of cross-links Hydroxydaunorubicin (also called doxorubicin or adriamycin), an intercalating agent which damages DNA by inserting itself between
Hodgkin lymphoma
[medical citation needed] The abbreviation stands for the four drugs adriamycin, bleomycin, vinblastine, and dacarbazine.[medical citation needed] Developed
Dexamethasone
lenalidomide, bortezomib (Velcade, Vel-dex), or a combination of doxorubicin (Adriamycin) and vincristine or bortezomib/lenalidomide/dexamethasone.[medical citation
Farmitalia
in Italy, but also at the world level with in particular the patent of Adriamycin, an anti-cancer drug qualified. From its creation, Farmaceutici Italia
Stomach cancer
capecitabine, BCNU (carmustine), methyl-CCNU (semustine) and doxorubicin (Adriamycin), as well as mitomycin C, and more recently cisplatin and taxotere, often
Muehrcke's nails
(Muehrcke's lines type) and longitudinal melanonychia after 5-fluorouracil/adriamycin/cyclophosphamide chemotherapy". Dermatology. 185 (3): 216–7. doi:10.1159/000247451